MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynamics, MRSAid is a valuable tool for the prevention of hospital-acquired infections.